← Back to Search

Behavioral Intervention

Vaccine Acceptance Interventions for Coronavirus in Prisons

N/A

Waitlist Available

Led By Lisa B Puglisi, MD

Research Sponsored by Yale University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 12 weeks

Awards & highlights

Study Summary

This trial aims to reduce COVID-19 cases in prisons by improving vaccine uptake through feasible interventions and studying their effectiveness.

Who is the study for?

This trial is for people detained in Pennsylvania correctional facilities, aiming to improve COVID-19 vaccine uptake. Those with severe physical or mental illness and those in special units like medical units are excluded.Check my eligibility

What is being tested?

The study tests the effectiveness of community engagement strategies developed by the ADVANCE Steering Committee to increase COVID-19 vaccination rates among incarcerated individuals and staff.See study design

What are the potential side effects?

Since this trial focuses on community engagement interventions rather than direct medical treatments, it does not involve typical medication side effects.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 12 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 12 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

COVID-19 vaccine acceptance rate

Secondary outcome measures

COVID-19 infections

Change in vaccination for other respiratory outbreaks

Deaths

+3 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: ADVANCE Steering Committee chosen interventionsExperimental Treatment1 Intervention

Interventions will be selected by the ADVANCE Steering Committee and will be rapidly deployed without additional effort on the part of front-line staff at four distinct levels: patient, provider, practice and prison level. Interventions will be tested one at a time in an iterative process. A participatory, assets-based framework will be used to identify acceptable and feasible strategies to improve vaccine acceptance. Each round of testing will include 1 month of preparation by the steering committee,12-week intervention period, and 2 months for analysis and rapid dissemination.

Group II: Treatment as usualActive Control1 Intervention

Participants receive standard interventions currently in use (treatment as usual).

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

National Institute on Minority Health and Health Disparities (NIMHD)NIH

380 Previous Clinical Trials

1,178,532 Total Patients Enrolled

Yale UniversityLead Sponsor

1,847 Previous Clinical Trials

2,699,406 Total Patients Enrolled

Lisa B Puglisi, MDPrincipal InvestigatorYale University

Media Library

ADVANCE Steering Committee interventions (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05796505 — N/A

Coronavirus Research Study Groups: ADVANCE Steering Committee chosen interventions, Treatment as usual

Coronavirus Clinical Trial 2023: ADVANCE Steering Committee interventions Highlights & Side Effects. Trial Name: NCT05796505 — N/A

ADVANCE Steering Committee interventions (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05796505 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this clinical trial actively enrolling participants at the moment?

"Data gleaned from clinicaltrials.gov suggests this research is presently recruiting subjects, with the trial being initially posted on September 26th 2022 and most recently updated March 21st 2023."

Answered by AI

How many individuals are being recruited for this experiment?

"Affirmative. Clinicaltrials.gov shows that, since its initial posting on September 26th 2022, this clinical trial has been actively seeking participants - 37122 in total across 1 site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Addressing Vaccine Acceptance in Carceral Settings Through Community Engagement

2024. "Addressing Vaccine Acceptance in Carceral Settings Through Community Engagement". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05796505.